A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus
The purpose of this research is to find out if ganaxolone can stop or decrease the seizure activity in participants who have SE and if ganaxolone is safe compared to placebo when given to participants who are on other anti-seizure medications. A placebo looks like the study drug but does not contain any active medicine. Researchers use a placebo to see if a study drug works better or is safer than not taking the study drug at all
This study is currently enrolling.